HLA-C*18:01 and KIR2DL2+C1 genetic variants are associated with low viral load in cART naive HIV-infected adult Zimbabweans

Autor: Mhandire, K, Tshabalala, M, Zijenah, L, Yindom, L, Mlambo, T, Mhandire, D, Musarurwa, C, Duri, K, Matarira, H, Dandara, C, Rowland-Jones, S, Stray-Pedersen, B

Publikováno v: Journal of Infection in Developing Countries. 12(12)

Introduction Polymorphisms in killer cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) gene families are implicated in differential outcomes of HIV infection. However, research findings on the influence ofKIRandHLA-Cpolymorphi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb433d51f87f632597f198991924cf94
http://ora.ox.ac.uk/objects/uuid:

Tackling long-term morbidity and mortality after successful tuberculosis treatment.

Autor: Marais BJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Electronic address: ben.marais@health.nsw.gov.au., Chakaya J; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya., Swaminathan S; World Health Organization, Geneva, Switzerland., Fox GJ; The University of Sydney Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Ehtesham NZ; ICMR-National Institute of Pathology, New Delhi, India., Ntoumi F; Université Marien Gouabi, Fondation Congolaise pour la Recherche Médicale, Brazzaville, Congo; Institute for Tropical Diseases, University of Tübingen, Germany., Zijenah L; Department of Immunology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Maurer M; Immunosurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt, Germany., Zumla A; Department of Infection, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Jun; Vol. 20 (6), pp. 641-642. Date of Electronic Publication: 2020 Mar 23.

Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study.

Autor: Barreto-Duarte, Beatriz^1,2,3,4,5 (AUTHOR) bruno.andrade@fiocruz.br, Villalva-Serra, Klauss^1,3 (AUTHOR), Miguez-Pinto, João P^1,3 (AUTHOR), Araújo-Pereira, Mariana^3,4,5 (AUTHOR), Campos, Vanessa M S^1,3 (AUTHOR), Rosier, Gabriela^3,4,6 (AUTHOR), Nogueira, Betânia M F^3,4,7 (AUTHOR), Queiroz, Artur T L^3,8 (AUTHOR), Rolla, Valeria C⁹ (AUTHOR), Cordeiro-Santos, Marcelo^10,11,12 (AUTHOR), Kritski, Afrânio L^2,13 (AUTHOR), Martinez, Leonardo¹⁴ (AUTHOR), Rebeiro, Peter F¹⁵ (AUTHOR), Sterling, Timothy R¹⁵ (AUTHOR), Rodrigues, Moreno M^3,16 (AUTHOR), Andrade, Bruno B^{1,2,3,4,5,6,7,15} (AUTHOR) bruno.andrade@fiocruz.br

Publikováno v: Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-9. 9p.

Comparison of microscopic and xpert MTB diagnoses of presumptive mycobacteria tuberculosis infection: retrospective analysis of routine diagnosis at Cape Coast Teaching Hospital.

Autor: Asare, Kwame Kumi^1,2 (AUTHOR) kwame.asare@ucc.edu.gh, Azumah, Daniel Edem³ (AUTHOR), Adu-Gyamfi, Czarina Owusua¹ (AUTHOR), Opoku, Yeboah Kwaku⁴ (AUTHOR), Adela, Edward Morkporkpor³ (AUTHOR), Afful, Philip¹ (AUTHOR), Abotsi, Godwin Kwami¹ (AUTHOR), Abban, Ernest Awuakye³ (AUTHOR), Duntu, Paul Ekow^1,5 (AUTHOR), Anyamful, Akwasi^1,6 (AUTHOR), Moses, Alberta Bedford³ (AUTHOR), Botchway, Emmanuel³ (AUTHOR), Mwintige, Philimon³ (AUTHOR), Kyei, Samuel^1,7 (AUTHOR), Amoah, Linda Eva⁸ (AUTHOR), Ekuman, Emmanuel Owusu³ (AUTHOR)

Publikováno v: BMC Infectious Diseases. 7/2/2024, Vol. 24 Issue 1, p1-10. 10p.

Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Autor: Pooran A; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, UCT, Cape Town, South Africa., Theron G; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, UCT, Cape Town, South Africa; Department of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, and South Africa Medical Research Council Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa., Zijenah L; Department of Immunology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Chanda D; University Teaching Hospital, Lusaka, Zambia., Clowes P; National Institute of Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany., Mwenge L; University Teaching Hospital, Lusaka, Zambia., Mutenherwa F; Biomedical Research and Training Institute, Harare, Zimbabwe., Lecesse P; Denver Health Residency in Emergency Medicine, Denver Health Medical Center, Denver, CO, USA., Metcalfe J; Division of Pulmonary and Critical Care Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA., Sohn H; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Hoelscher M; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany; German Centre for Infection Research, Munich, Germany., Pym A; South African Medical Research Council, Africa Health Research Institute, and Durban, South Africa., Peter J; Department of Medicine, UCT, Cape Town, South Africa., Dowdy D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, UCT, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: keertan.dheda@uct.ac.za.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2019 Jun; Vol. 7 (6), pp. e798-e807.